Get started
OSE IMMUNOTHERAPEUTICSOSE IMMUNOTHERAPEUTICSOSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

OSE chart


Full chart

OSE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪125.19 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
3.330
Basic EPS (TTM)
1.715 EUR
Net income (FY)
‪37.45 M‬ EUR
Revenue (FY)
‪69.88 M‬ EUR
Shares float
‪16.78 M‬
Beta (1Y)
1.10

About OSE IMMUNOTHERAPEUTICS


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Nicolas Poirier
Website
ose-immuno.com
Headquarters
Nantes
Founded
2004
ISIN
FR0012127173
FIGI
BBG008891XD6
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OSE news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as OSE.

Frequently Asked Questions


The current price of OSE is 5.855 EUR — it has increased by 1.66% in the past 24 hours. Watch OSE IMMUNOTHERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange OSE IMMUNOTHERAPEUTICS stocks are traded under the ticker OSE.
OSE stock has fallen by −3.09% compared to the previous week, the month change is a −7.04% fall, over the last year OSE IMMUNOTHERAPEUTICS has showed a 3.81% increase.
We've gathered analysts' opinions on OSE IMMUNOTHERAPEUTICS future price: according to them, OSE price has a max estimate of 21.00 EUR and a min estimate of 13.00 EUR. Watch OSE chart and read a more detailed OSE IMMUNOTHERAPEUTICS stock forecast: see what analysts think of OSE IMMUNOTHERAPEUTICS and suggest that you do with its stocks.
OSE reached its all-time high on Feb 22, 2021 with the price of 15.800 EUR, and its all-time low was 2.700 EUR and was reached on Dec 21, 2018. View more price dynamics on OSE chart.
See other stocks reaching their highest and lowest prices.
OSE stock is 1.55% volatile and has beta coefficient of 1.10. Track OSE IMMUNOTHERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is OSE IMMUNOTHERAPEUTICS there?
Today OSE IMMUNOTHERAPEUTICS has the market capitalization of ‪129.48 M‬, it has increased by 8.66% over the last week.
Yes, you can track OSE IMMUNOTHERAPEUTICS financials in yearly and quarterly reports right on TradingView.
OSE IMMUNOTHERAPEUTICS is going to release the next earnings report on Sep 25, 2025. Keep track of upcoming events with our Earnings Calendar.
OSE net income for the last half-year is ‪−19.73 M‬ EUR, while the previous report showed ‪57.17 M‬ EUR of net income which accounts for −134.51% change. Track more OSE IMMUNOTHERAPEUTICS financial stats to get the full picture.
No, OSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OSE IMMUNOTHERAPEUTICS EBITDA is ‪32.76 M‬ EUR, and current EBITDA margin is 52.14%. See more stats in OSE IMMUNOTHERAPEUTICS financial statements.
Like other stocks, OSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OSE IMMUNOTHERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OSE IMMUNOTHERAPEUTICS technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OSE IMMUNOTHERAPEUTICS stock shows the sell signal. See more of OSE IMMUNOTHERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.